Description

COMPOSITION: Each uncoated bilayered tablet contains Montelukast Sodium eq. to Montelukast 10 mg, Fexofenadine Hydrochloride 120 mg & Acebrophylline SR 200 mg

FORMULATION: TABLETS

STATUS: PRESCRIPTION ONLY DRUG

DESCRIPTION: Minolast-FXA tablet contains Montelukast, a Lukotriene inhibitor that relieves inflammation and oedema; Fexofenadine, an anti-allergic that relieves allergy & Acebrophylline in sustain release form which dilates airways of the respiratory tract and removes mucus from them. It is prescribed in cases of long standing asthma, respiratory tract congestion & allergic manifestations & other chronic lung diseases.

SIDE EFFECTS: Main side effects are constipation, heart burn, loss of appetite, headache, drowsiness, dizziness, abdominal pain, dyspepsia & nausea.

DOSAGE/DIRECTIONS FOR USE: As Prescribed by Physician